"Creatine Kinase, MB Form" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An isoenzyme of creatine kinase found in the CARDIAC MUSCLE.
Descriptor ID |
D052279
|
MeSH Number(s) |
D08.811.913.696.640.150.625
|
Concept/Terms |
Creatine Kinase, MB Form- Creatine Kinase, MB Form
- Myocardial Creatine Kinase
- Creatine Kinase, Myocardial
- Kinase, Myocardial Creatine
- Isoenzyme CPK-MB
- CPK-MB, Isoenzyme
- Isoenzyme CPK MB
- MB Creatine Kinase
- Creatine Kinase, MB
- Kinase, MB Creatine
|
Below are MeSH descriptors whose meaning is more general than "Creatine Kinase, MB Form".
Below are MeSH descriptors whose meaning is more specific than "Creatine Kinase, MB Form".
This graph shows the total number of publications written about "Creatine Kinase, MB Form" by people in this website by year, and whether "Creatine Kinase, MB Form" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 2 | 2 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 2 | 0 | 2 |
2007 | 2 | 1 | 3 |
2008 | 1 | 1 | 2 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Creatine Kinase, MB Form" by people in Profiles.
-
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous?Coronary Intervention. JACC Cardiovasc Interv. 2018 05 14; 11(9):856-864.
-
Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA?CER) trial. Eur Heart J. 2013 Jun; 34(23):1723-31.
-
A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial. Heart. 2013 Sep; 99(17):1282-7.
-
Elevated cardiac biomarkers with normal right ventricular size indicate an unlikely diagnosis of acute pulmonary embolism in stable patients. Clin Appl Thromb Hemost. 2011 Nov-Dec; 17(6):E153-7.
-
The role of postmortem cardiac markers in the diagnosis of acute myocardial infarction. J Forensic Sci. 2010 Jul; 55(4):1088-91.
-
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY). Am J Cardiol. 2009 Nov 15; 104(10):1330-5.
-
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction. Am J Cardiol. 2008 Nov 01; 102(9):1119-24.
-
Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol. 2008 Sep 01; 102(5):530-4.
-
Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome? Catheter Cardiovasc Interv. 2007 Nov 15; 70(6):826-31.
-
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. J Thorac Cardiovasc Surg. 2007 Jun; 133(6):1604-11.